-
support to foster NRC success in obtaining project program and training grants. The NRC is comprised of state-of-the-art research labs with core facilities for microscopy, rodent behavior, and neuroimaging
-
-on expertise in state of the art genetic and epigenetic approaches coupled with next-generation sequencing technologies to gain a broader understanding of MOA and target validation of novel cancer therapeutics
-
preclinical research and advance our clinical and pre-clinical drug programs in the field of cancer cell biology. Our ideal candidate will have a strong background employing state-of-the art approaches to gain
-
& scope, assuring quality and control, and ensuring general operational efficiency. 5. Maintains accurate records of experiments and analyses performed, conducts relevant literature searches, and maintains
-
with project teams to establish screening strategies, interpret results, and make decisions to drive programs forward. Write protocols, maintain ELN, and regularly review literature to m aintain
-
National Human Genome Research Institute, NIH | Rockville, Maryland | United States | about 2 months ago
Research (DIR; see genome.gov/dir), located in Rockville, Maryland. NISC is a nationally recognized state-of-the-art, trans-NIH genome sequencing center that produces more than 50 trillion bases of DNA
-
, scalable processes Be recognized as a technical expert by demonstrating advanced technical abilities Employ state-of-the art technologies, including flow chemistry, high-throughput experimentation, catalysis
-
includes a Nobel Laureate. The Department also includes five members of the National Academy of Sciences, four members of the National Academy of Medicine, and four members of the American Academy of Arts
-
to review literature to formulate new ideas and have the ability to work independently as well as with an interdisciplinary team of scientists in a highly collaborative environment. The candidate will have
-
&D. KEY RESPONSIBILITIES Participate in designing immune profiling experiments for pre-clinical animal studies or clinical trials. Familiar with state-of-art technology related to bulk RNAseq, single